European Biosimilar Market Report 2022-2027: Featuring Key Players Novartis, Pfizer, Samsung Bioepis & Others
July 04, 2022 06:33 ET
|
Research and Markets
Dublin, July 04, 2022 (GLOBE NEWSWIRE) -- The "Biosimilar Market in Europe: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Global Biosimilars Partnering Terms and Agreements 2010 to 2022: Trends in Biosimilars Dealmaking in the Biopharma Industry since 2010
June 27, 2022 06:58 ET
|
Research and Markets
Dublin, June 27, 2022 (GLOBE NEWSWIRE) -- The "Global Biosimilars Partnering Terms and Agreements 2010 to 2022" report has been added to ResearchAndMarkets.com's offering. This report is intended...
Global Biosimilar Monoclonal Antibodies Market Report 2022: Market is Expected to Reach $10.64 Billion in 2026 at a CAGR of 18.1% - Long-term Forecast to 2031
June 01, 2022 05:13 ET
|
Research and Markets
Dublin, June 01, 2022 (GLOBE NEWSWIRE) -- The "Biosimilar Monoclonal Antibodies Global Market Report 2022: By Type, By Application, By Compound" report has been added to ResearchAndMarkets.com's...
Samsung Bioepis Announces New Data on Adalimumab Biosimilar, SB5 at the Annual European Congress of Rheumatology (EULAR 2022)
May 31, 2022 18:05 ET
|
Samsung Bioepis
Samsung Bioepis and Biogen to present one abstract and one poster at EULAR 2022 on adalimumab biosimilar, SB5 including Phase 1 study of a new SB5 formulation and a pan-European real-world study,...
Biopharmaceuticals Contract Manufacturing Market Report 2022: A $27.3 Billion Market by 2030 - Rise in Investment by CMOs for Capacity Expansion
May 26, 2022 08:33 ET
|
Research and Markets
Dublin, May 26, 2022 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals Contract Manufacturing Market Size, Share, & Trend Analysis Report by Source, by Service (Upstream, Downstream, Fill/Finish), by...
State of the Biopharmaceutical Industry, 2022 Report - As Industries Emerge from the impact of COVID-19, 2022 will be a Year of Readjustments and Transition
April 25, 2022 08:23 ET
|
Research and Markets
Dublin, April 25, 2022 (GLOBE NEWSWIRE) -- The "State of the Biopharmaceutical Industry 2022" report has been added to ResearchAndMarkets.com's offering. In this "State of the Biopharmaceutical...
Global Biologics Market Research Report 2022: Revised FDA Regulations to Facilitate Biologics Drug Development - Long-term Forecast to 2030
April 22, 2022 07:03 ET
|
Research and Markets
Dublin, April 22, 2022 (GLOBE NEWSWIRE) -- The "Biologics Global Market Opportunities And Strategies To 2030, By Type, Distribution Channel, Route Of Administration, Drug Classification, Mode Of...
Insights on the Monoclonal Antibodies North America Market to 2030 - Featuring Abbvie, Amgen and Bayer Among Others
April 08, 2022 06:48 ET
|
Research and Markets
Dublin, April 08, 2022 (GLOBE NEWSWIRE) -- The "North America Monoclonal Antibodies Market 2020-2030 by Source, Category, Production Type, Application, End User, and Country: Trend Forecast and...
Global Biosimilar Market to Generate a Revenue of $83,836.40 Million by 2028, Growing at a CAGR of 24.90% from 2021 to 2028 | Exclusively Available [170-Pages] by Research Dive
March 29, 2022 09:00 ET
|
Research Dive
New York, USA, March 29, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global biosimilar market is expected to garner a revenue of $83,836.40 million by 2028,...
$3.27 Billion Worldwide Oncology Biosimilars Industry to 2031 - Identify Growth Segments for Investment
March 22, 2022 05:33 ET
|
Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Oncology Biosimilars Global Market Report 2022: By Drug, By Cancer, By Distribution" report has been added to ResearchAndMarkets.com's offering. This...